Other Titles
Improving nursing care and outcomes for patients living with end-stage renal disease [Symposium]
Abstract
Globally, two million patients are undergoing hemodialysis for end-stage renal disease. Hemodialysis patients have higher morbidity and mortality associated with adverse events and a complex treatment regimen. This symposium explores patient, provider, and system factors that can be leveraged to decrease adverse events, readmission, and improve symptom management and quality-of-life.
Sigma Membership
Xi
Lead Author Affiliation
University of Pennsylvania, Philadelphia, Pennsylvania, USA
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
End-Stage Renal Disease, Patient Outcomes, Sodium
Recommended Citation
Clark-Cutaia, Maya Nicole, "Sodium-restricted diets and symptoms in end-stage renal disease: A randomized controlled trial" (2017). INRC (Congress). 333.
https://www.sigmarepository.org/inrc/2017/presentations_2017/333
Conference Name
28th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Dublin, Ireland
Conference Year
2017
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Sodium-restricted diets and symptoms in end-stage renal disease: A randomized controlled trial
Dublin, Ireland
Globally, two million patients are undergoing hemodialysis for end-stage renal disease. Hemodialysis patients have higher morbidity and mortality associated with adverse events and a complex treatment regimen. This symposium explores patient, provider, and system factors that can be leveraged to decrease adverse events, readmission, and improve symptom management and quality-of-life.